Holen Sie sich die Stockscreener-App
1.59
0.63%
0.01
Schlusskurs vom Vortag:
$1.58
Offen:
$1.57
24-Stunden-Volumen:
79,845
Relative Volume:
0.44
Marktkapitalisierung:
$41.83M
Einnahmen:
$9.06M
Nettoeinkommen (Verlust:
$-50.39M
KGV:
-0.8281
EPS:
-1.92
Netto-Cashflow:
$5.89M
1W Leistung:
+6.00%
1M Leistung:
+3.92%
6M Leistung:
+22.31%
1J Leistung:
-5.92%
1-Tages-Spanne:
$1.57
$1.59
1-Wochen-Bereich:
$1.40
$1.59
52-Wochen-Spanne:
$0.8502
$2.093
Lava Therapeutics Nv Stock (LVTX) Company Profile
Firmenname
Lava Therapeutics Nv
Sektor
Branche
Telefon
31 6 3000 3035
Adresse
YALELAAN 62, UTRECHT
Vergleichen Sie LVTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LVTX
Lava Therapeutics Nv
|
1.59 | 41.56M | 9.06M | -50.39M | 5.89M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.62 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.98 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
729.76 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
329.84 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Lava Therapeutics Nv Stock (LVTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-12 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-10-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-04-19 | Eingeleitet | Jefferies | Buy |
| 2021-04-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Lava Therapeutics Nv Aktie (LVTX) Neueste Nachrichten
LAVA Therapeutics (NASDAQ:LVTX) Stock Price Up 5.1% – Should You Buy? - Defense World
Published on: 2025-09-22 10:01:15 - newser.com
Published on: 2025-09-22 11:09:12 - newser.com
Measuring LAVA Therapeutics N.V.’s beta against major indicesIPO Watch & Risk Managed Investment Signals - newser.com
RNA Editing Market Key Players AnalysisQIAGEN N.V., - openPR.com
Using R and stats models for LAVA Therapeutics N.V. forecasting2025 Volume Leaders & Daily Price Action Insights - newser.com
What data driven models say about LAVA Therapeutics N.V.’s future2025 Earnings Impact & Short-Term High Return Ideas - newser.com
Sectors Review: Is LAVA Therapeutics NV currently under institutional pressureJuly 2025 Action & Risk Controlled Swing Alerts - خودرو بانک
Is LAVA Therapeutics N.V. stock bottoming outJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - newser.com
Applying big data sentiment scoring on LAVA Therapeutics N.V.July 2025 Patterns & Fast Entry High Yield Tips - newser.com
Short interest data insights for LAVA Therapeutics N.V.July 2025 Summary & Trade Opportunity Analysis Reports - newser.com
Can machine learning forecast LAVA Therapeutics N.V. recovery2025 Valuation Update & Precise Buy Zone Identification - newser.com
Using portfolio simulators with LAVA Therapeutics N.V. includedJuly 2025 Recap & Low Risk Growth Stock Ideas - newser.com
Is LAVA Therapeutics N.V. stock reversal real or fakeJuly 2025 Catalysts & Safe Entry Momentum Stock Tips - newser.com
Fed Meeting: How cyclical is LAVA Therapeutics NVs revenue streamJuly 2025 Opening Moves & Daily Volume Surge Trade Alerts - خودرو بانک
Versant sells LAVA Therapeutics (LVTX) stock worth $2.5 million By Investing.com - Investing.com Nigeria
Quantitative breakdown of LAVA Therapeutics N.V. recent move2025 Momentum Check & Real-Time Chart Pattern Alerts - newser.com
Versant sells LAVA Therapeutics (LVTX) stock worth $2.5 million - Investing.com India
Will LAVA Therapeutics N.V. continue its uptrendInsider Buying & Breakout Confirmation Trade Signals - newser.com
LAVA Therapeutics N.V. stock outlook for YEARWall Street Watch & Daily Stock Trend Watchlist - newser.com
Is LAVA Therapeutics N.V. forming a reversal patternJuly 2025 Closing Moves & Fast Gain Stock Trading Tips - newser.com
Aug Action: Is Reynolds Consumer Products Inc stock risky to hold nowJuly 2025 Big Picture & Advanced Technical Analysis Signals - خودرو بانک
Street Watch: Can LAVA Therapeutics NV outperform in the next rally2025 Momentum Check & Fast Momentum Entry Tips - خودرو بانک
Aug Volume: Is Canada Life Capital Trust Preferred Security stock a good dividend stockMarket Movers & Weekly Stock Performance Updates - khodrobank.com
Aug PostEarnings: Is LAVA Therapeutics NV forming higher highs and higher lows2025 Momentum Check & Safe Entry Trade Reports - خودرو بانک
Published on: 2025-09-16 20:01:00 - newser.com
Is LAVA Therapeutics NV benefiting from innovation trendsPortfolio Update Report & Technical Pattern Based Signals - خودرو بانک
How does LAVA Therapeutics N.V. compare to its peersMarket Growth Summary & High Conviction Trade Alerts - خودرو بانک
Price Action: Is LAVA Therapeutics N.V. a stock for growth or value investors2025 Growth vs Value & Fast Entry and Exit Trade Plans - خودرو بانک
Is LAVA Therapeutics NV a stock for growth or value investorsJuly 2025 Final Week & Weekly Stock Breakout Alerts - خودرو بانک
Gainers Report: Is WTFCP stock trending bullishDividend Hike & Target Return Focused Picks - خودرو بانک
Fed Meeting: How does LAVA Therapeutics N.V. compare to its peersStock Surge & Accurate Intraday Trade Tips - khodrobank.com
Published on: 2025-09-15 23:53:37 - خودرو بانک
Earnings Beat: Is LAVA Therapeutics NV a good ESG investmentGlobal Markets & Consistent Income Trade Recommendations - خودرو بانک
Aug Highlights: What is the Moat Score of LAVA Therapeutics NVQuarterly Trade Review & Low Drawdown Investment Ideas - خودرو بانک
Analyzing recovery setups for LAVA Therapeutics N.V. investorsWeekly Volume Report & Free AI Powered Buy and Sell Recommendations - newser.com
Aug Outlook: Is LAVA Therapeutics N.V. in a long term uptrend2025 Price Action Summary & Long-Term Capital Growth Ideas - خودرو بانک
Finanzdaten der Lava Therapeutics Nv-Aktie (LVTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.30%
2.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):